As Oct4/Nanog is actively involved in EMT process via regulation on Stat3/Snail pathway, we postulate that inhibition of Stat3 pathway would be a promising therapeutic strategy to control stem cells-associated EMT phenotype in HCC. The gene discussed is STAT3; the disease is hepatocellular carcinoma.